等待开盘 09-30 09:30:00 美东时间
-0.120
-1.96%
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Joby Aviation (JOBY) completed its first autonomous flight across the U.S., flying more than 3K miles with zero control inputs from its onboard safety pilot. Leaving Concord, California, the converte...
09-18 23:35
Aircraft equipped with Joby’s autonomy technology completes first-ever autonomous flight across the United States, arriving in North Carolina’s Outer Banks Aircraft covered 3,199 miles with zero control inputs from onboard safety pilot, including autonomous taxi, takeoff, cruise, and landing, superv...
09-18 20:02
折叠屏iPhone获追捧!苹果多张末日Call劲升逾300%;甲骨文Q1业绩胜预期,逾6成多头加码捞底成功;美光热门Call豪赌今夜重回1000美元关>>
09-11 19:37
Joby Aviation, Inc. (NYSE:JOBY) touched a fresh 52-week low of $6.25 on Thursday, even as the company kicked off a month-long, 10-state autonomous flight tour meant to prove its technology is ready for real-world use. JOBY stock is moving. See the real-time price action here. Coast-To-Coast Tour B...
09-11 03:34
Joby Aviation ($JOBY) disclosed that its autonomous J208 aircraft has started a...
09-11 02:14
Joby Aviation Inc. (NYSE:JOBY) shares remain flat Thursday after touching a fresh 52-week low intraday, as the company kicked off a week of real-world flight demonstrations in Texas alongside a separate coast-to-coast autonomy tour. Here’s what you need to know. Joby Aviation stock is showing downwa...
09-11 01:52
Merlin demonstrated its AI-powered Merlin Pilot™ platform at the Texas Department of Transportation’s Project NEXUS kickoff, showcasing autonomous takeoff, landing, and in-flight threat avoidance. The event highlighted Merlin's role in advancing Advanced Air Mobility (AAM) technologies to enhance safety, efficiency, and sustainability in aviation. Merlin's participation supports the integration of autonomous flight into the U.S. National Airspace...
09-10 20:01
On CNBC’s “Mad Money Lightning Round,” Jim Cramer said he is not going to put his money on AstraZeneca PLC (NYSE:AZN) because it has been missing some of its trials. As per recent news, AstraZeneca on Tuesday secured a key FDA approval for a new breast cancer treatment and reported strong Phase 3 tr...
09-09 20:56